XML 72 R59.htm IDEA: XBRL DOCUMENT v3.19.1
INTANGIBLE ASSETS AND GOODWILL - Narrative (Details) - USD ($)
3 Months Ended 12 Months Ended
Oct. 01, 2018
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Mar. 01, 2018
Jan. 01, 2018
Dec. 31, 2017
Goodwill [Line Items]              
Impairment of intangible assets   $ 3,000,000 $ 34,000,000        
Net loss attributable to Bausch Health Companies Inc.   (52,000,000) $ (2,581,000,000)        
Earnings per share, basic and diluted (in dollars per share)     $ (7.36)        
Net carrying amount   11,683,000,000   $ 12,001,000,000      
Goodwill impairment   0 $ 2,213,000,000        
Percentage of fair value in excess of carrying value (more than)           15.00%  
Goodwill   13,121,000,000   13,142,000,000     $ 15,593,000,000
Accumulated goodwill impairment charges   3,711,000,000          
Ortho Dermatologics              
Goodwill [Line Items]              
Goodwill impairment       2,213,000,000      
Dentistry Reporting Unit              
Goodwill [Line Items]              
Goodwill impairment $ 109,000,000     $ 109,000,000      
Reporting Units Excluding Dentistry              
Goodwill [Line Items]              
Goodwill impairment $ 0            
Branded Rx | Adjustments              
Goodwill [Line Items]              
Goodwill         $ 115,000,000    
Branded Rx | Salix              
Goodwill [Line Items]              
Goodwill impairment     1,970,000,000        
Branded Rx | Ortho Dermatologics              
Goodwill [Line Items]              
Goodwill impairment     243,000,000        
Bausch Lomb/International And U.S. Diversified Products Segments | Adjustments              
Goodwill [Line Items]              
Goodwill     (115,000,000)        
Minimum              
Goodwill [Line Items]              
Reporting unit, impairment test, long-term growth rate 1.00%            
Reporting unit, impairment test, estimated cash flows, discount rate 7.50%            
Maximum              
Goodwill [Line Items]              
Reporting unit, impairment test, long-term growth rate 3.00%            
Reporting unit, impairment test, estimated cash flows, discount rate 14.00%            
Xifaxan              
Goodwill [Line Items]              
Net carrying amount   4,713,000,000          
Xifaxan | Intangible Assets, Amortization Period              
Goodwill [Line Items]              
Net loss attributable to Bausch Health Companies Inc.   $ 118,000,000          
Earnings per share, basic and diluted (in dollars per share)   $ 0.34          
Held-for-sale              
Goodwill [Line Items]              
Impairment of long-lived assets     4,000,000        
Product/patent assets              
Goodwill [Line Items]              
Impairment of finite-lived intangible assets     $ 6,000,000